These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3265488)

  • 1. Immunophenotyping of leukaemias and non-Hodgkin's lymphomas. Immunological markers and their CD codes.
    van Dongen JJ; Adriaansen HJ; Hooijkaas H
    Neth J Med; 1988 Dec; 33(5-6):298-314. PubMed ID: 3265488
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology.
    Schuurman HJ; van Baarlen J; Huppes W; Lam BW; Verdonck LF; van Unnik JA
    Am J Pathol; 1987 Oct; 129(1):140-51. PubMed ID: 3310650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The immunophenotype in leukemia].
    Pizzolo G; Vinante F; Benedetti F; Vincenzi C; Morosato L; De Sabata D
    Haematologica; 1991 Jun; 76 Suppl 3():19-25. PubMed ID: 1752513
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunophenotypic analysis of non-Hodgkin's lymphomas.
    La Via MF; Self SE
    Recenti Prog Med; 1990 Oct; 81(10):629-34. PubMed ID: 2291006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of HLA-DR, CD38 and CD71 markers to activation, proliferation and differentiation of some human leukemia and lymphoma cells.
    Glasová M; Koníková E; Stasáková J; Babusíková O
    Neoplasma; 1998; 45(2):88-95. PubMed ID: 9687889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotyping of Non-Hodgkin's lymphomas in Sudan.
    Hamid KH; Elduma AH; Mohamed BM; Salih MM
    Pan Afr Med J; 2014; 18():82. PubMed ID: 25400849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and differentiation antigen expression in B-cell non-Hodgkin's lymphoma.
    Salter DM; Krajewski AS; Cunningham S
    J Pathol; 1988 Mar; 154(3):209-22. PubMed ID: 3280770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic approaches to the classification of non-Hodgkin's lymphomas.
    Grogan TM; Spier CM; Richter LC; Rangel CS
    Cancer Treat Res; 1988; 38():31-148. PubMed ID: 2908600
    [No Abstract]   [Full Text] [Related]  

  • 9. Leu-M1 antigen expression in acute leukaemias.
    de Mascarel A; Coindre JM; de Mascarel I; David B; Trojani M; Broustet A
    J Pathol; 1987 Nov; 153(3):225-32. PubMed ID: 3501459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of HLA antigens class II in differentiation of normal and pathological B-lymphocytes. II. HLA-D expression in leukemia and non-Hodgkin's lymphoma].
    Pluta A
    Acta Haematol Pol; 1990; 21(1):118-23. PubMed ID: 2260404
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ki-1 non-Hodgkin's lymphoma. A multihospital study of 21 cases].
    Rivas C; Obeso G; Piris M; Castrillo JM; Bellas C; Acevedo A; Martín C; Campo E; Gamallo C; Font M
    Rev Clin Esp; 1989 Mar; 184(5):238-44. PubMed ID: 2549584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological classification of high grade non-Hodgkin's lymphomas (NHL) in children.
    Pituch-Noworolska A; Miezyński W
    Pol J Pathol; 1994; 45(4):257-61. PubMed ID: 7697326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoperoxidase staining of non-Hodgkin's lymphomas for T-cell lineage associated antigens in paraffin sections. Comparison of the performance characteristics of four commercially available antibody preparations.
    Kurtin PJ; Roche PC
    Am J Surg Pathol; 1993 Sep; 17(9):898-904. PubMed ID: 8352374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic analysis of a thousand cases of acute leukemia. French Groupe d'Etude Immunologique des Leucémies (GEIL).
    Béné MC; Boumsell L; Vannier JP; Garand R; Solary E; Faure G; Bernard A
    Nouv Rev Fr Hematol (1978); 1989; 31(2):133-6. PubMed ID: 2671926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of cellular markers in Epstein-Barr virus-positive Hodgkin's disease.
    Bai MC; Jiwa NM; Horstman A; Vos W; Kluin PH; Van der Valk P; Mullink H; Walboomers JM; Meijer CJ
    J Pathol; 1994 Sep; 174(1):49-55. PubMed ID: 7525910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical significance of the immunological phenotype in non-Hodgkin's lymphomas].
    Golenkov AK; Miterev GIu; Popov VM; Shakher AL
    Ter Arkh; 1995; 67(7):30-2. PubMed ID: 7482301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of monoclonal antibody phenotyping and cellular DNA content in non-Hodgkin's lymphoma. The Southeastern Cancer Study Group experience.
    Wain SL; Braylan RC; Borowitz MJ
    Cancer; 1987 Nov; 60(10):2403-11. PubMed ID: 3499212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
    Moreno MM; Fernández-Flores A; Paradela A; Rodríguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
    Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunophenotype of 37 childhood acute lymphoblastic leukemia patients].
    Malcorra JJ; Balda I; Sánchez Godoy P; Campo C; Negrín M; Hernández D; Hernández F
    An Esp Pediatr; 1988 Oct; 29 Suppl 34():31-4. PubMed ID: 3265045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.